← All trials
NCT00941135
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2009
- Primary completion
- May 31, 2013
- Completion date
- May 31, 2013
- First posted
- Jul 17, 2009
- Last posted
- Sep 29, 2011
- Enrollment
- 70
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fundacion Miguel ServetLead sponsor
- Clinica Universidad de NavarraOverall official - principal investigator
- University of NavarraCollaborator
- Clinica Universidad de NavarraOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.